Technology and Investment

Volume 4, Issue 2 (May 2013)

ISSN Print: 2150-4059   ISSN Online: 2150-4067

Google-based Impact Factor: 0.47  Citations  

External Innovation Implementation Determinants and Performance Measurement: A Case Study from the Pharmaceutical Industry

HTML  Download Download as PDF (Size: 407KB)  PP. 131-143  
DOI: 10.4236/ti.2013.42016    5,976 Downloads   8,852 Views  Citations

ABSTRACT

With an increasing amount of externally sourced innovations, a major success factor for innovation-dependent indus- tries such as the pharmaceutical industry is to successfully implement innovations from outside. Existing frameworks emphasize creating a strong climate for implementation by developing the learning capabilities of the organization, but there is still much to be learned about the process of implementing innovations that have been in-sourced by companies. As a research setting that is particularly innovation-driven and not well-studied yet, this study examines the key deter- minants for innovation implementation based on a case study in the pharmaceutical industry. The results of 25 expert interviews and a survey with 67 respondents led to the resulting framework and a corresponding performance meas- urement system. The results reveal the importance of supporting systems and show differences in perception of early and late Research & Development functions.

Share and Cite:

M. Coates and L. Bals, "External Innovation Implementation Determinants and Performance Measurement: A Case Study from the Pharmaceutical Industry," Technology and Investment, Vol. 4 No. 2, 2013, pp. 131-143. doi: 10.4236/ti.2013.42016.

Cited by

[1] Chief Executive Officer's traits and open innovation in small and medium enterprises: the mediating role of innovation climate
2020
[2] An exploration of knowledge creation processes in Open Innovation
2020
[3] The innovation process from an idea to a final product: a review of the literature
2018
[4] Post-M&A Resource Orchestration: The Moderating Role of Chief Strategy Officer (CSO) Capabilities
Dissertation, 2017
[5] THE INTEGRATED MODEL OF POST-M&A RESOURCE ORCHESTRATION: A STUDY IN THE MULTINATIONAL PHARMACEUTICAL FIRMS
2017
[6] Analiza aktivnosti farmacevtskega podjetja kot podpora odločitvi za zunanje izvajanje aktivnosti
2016
[7] Open Innovation and Involvement of End-Users in the Medical Device Technologies' Design & Development Process: End-Users' Perspectives
2016
[8] Corporate Entrepreneurship in Pharma R&D Organizational Transformations
2016
[9] 個別化医療開発における企業の能力
2015
[10] Entrepreneurial management, effective governance, and high-performance teams at central research and development laboratories: a multi-case study
International Journal of Teaching and Case Studies, 2015
[11] Companion Diagnostics & HEOR Outsourcing Governance: Application of Corporate Entrepreneurship Framework.
2014
[12] Inventory Management and Logistics Cost Reduction: A Case of a Malaysia Herbal Medicine Company
2013
[13] Desenvolvimento e validação de uma medida de clima organizacional com foco em inovação

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.